TYRP1 and Unverricht-Lundborg disease: High levels of CatB were reported in serum of human patients with surgically resected temporal lobes (59) and in glial cells of progressive myoclonic epilepsies (57), suggesting that CatB can be a potential therapeutic target for certain epilepsies (58).